Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
#2. Clinical Impact of the Pro-Healing<br />
Stent and Beyond<br />
Endovascular Arena, Level 1<br />
Co-sponsored by Orbus Neich Medical<br />
Korea, Ltd<br />
Chairperson: Seung-Jung Park<br />
12:45 PM<br />
12:50 PM<br />
1:05 PM<br />
1:20 PM<br />
1:35 PM<br />
1:45 PM<br />
Opening Address<br />
Seung-Jung Park<br />
Development of a Novel<br />
Sirolimus Eluting Pro-Healing<br />
Stent<br />
Juan Granada<br />
Genous Stent in Real-World<br />
Experience and TRIAS HR Pilot<br />
Study Long Term Follow Up<br />
Margo Klomp<br />
AMI Intervention in DES Era<br />
and Beyond<br />
Harry Suryapranata<br />
Q & A followed by Closing<br />
Remarks<br />
Seung-Jung Park<br />
Adjourn<br />
#3. The Future of Drug-Eluting Stent-<br />
BioMatrix TM : The New Biodegradable<br />
Abluminally Coated Drug-Eluting<br />
Stent with Completely Biodegradable<br />
Polymer and a Long Term Safety<br />
Profile of a Bare-Metal Stent<br />
Room 1-1(Calla Room), Level 1<br />
Co-Sponsored by Biosensors & Jung Sung<br />
Medical<br />
Moderators: Yangsoo Jang<br />
Junghan Yoon<br />
12:45 PM<br />
12:50 PM<br />
1:05 PM<br />
1:15 PM<br />
Welcome and Opening Address<br />
Assessement of LEADERS 12<br />
Months Result<br />
Patrick W. Serruys<br />
LEADERS: Analysis of 9<br />
Months OCT Results<br />
Patrick W. Serruys<br />
Asia Pacific BioMatrixTM Clinical Results<br />
Teguh Santoso<br />
1:25 PM<br />
1:35 PM<br />
1:40 PM<br />
1:45 PM<br />
#4. Prasugrel: A Novel Thienopyridine<br />
Antiplatelet Agent<br />
Room 2-1(Presidio 1 & 2), Level 2<br />
Sponsored by Lilly Korea & Daiichi Sankyo Korea<br />
Moderators: Roxana Mehran<br />
Seong-Wook Park<br />
12:45 PM<br />
12:50 PM<br />
1:10 PM<br />
1:30 PM<br />
1:40 PM<br />
Welcome Address<br />
Seong-Wook Park<br />
New Paradigms in Treatment<br />
of ACS/AMI<br />
Roxana Mehran<br />
Potential Ethnic Difference<br />
with Prasugrel Between<br />
Caucasian and Asian<br />
Populations<br />
Ronan Kelly<br />
Q & A<br />
Adjourn<br />
#5. Vulnerable Plaque: Identification &<br />
Therapeutic Intervention<br />
Symposium Arena, Level 3<br />
Co-sponsored by Clinical Research Center<br />
for Ischemic Heart Disease, The Korea<br />
Ministry of Health and Welfare<br />
Moderators: Gary S. Mintz<br />
Cheol Whan Lee<br />
12:45 PM<br />
1:00 PM<br />
BioMatrixTM : The New<br />
Biodegradable Abluminally<br />
Coated DES BioMatrixTM Clinical <strong>Program</strong><br />
Teguh Santoso<br />
Questions & Answers<br />
Conclusion & Closing Remarks<br />
Adjourn<br />
Mechanisms of Plaque<br />
Destabilization: Pathologic<br />
Observation<br />
Renu Virmani<br />
In Search of Vulnerable<br />
Plaque: Summary of Current<br />
Issues<br />
Gary S. Mintz<br />
1:15 PM<br />
1:30 PM<br />
1:45 PM<br />
1:50 PM<br />
Wednesday, April 22, 2009<br />
Regional Therapy: FIH Experience<br />
of A Novel Self Expandable Nitinol<br />
Device<br />
Juan Granada<br />
Systemic Therapy for Plaque<br />
Stabilization: New Drugs Targeting<br />
LP-PLA2<br />
Patrick W. Serruys<br />
Discussion<br />
Adjourn<br />
#6. Now Is the Switching Point to Move<br />
to the Bivalirudin Monotheraphy<br />
Tutorial Arena, Level 4<br />
Sponsored by Asia Pharm.Ind.Co.,Ltd<br />
Moderators: Young-Hak Kim<br />
Gregg W. Stone<br />
12:45 PM<br />
12:50 PM<br />
1:10 PM<br />
1:30 PM<br />
1:40 PM<br />
Welcome Address<br />
Young-Hak Kim<br />
STEMI and NSTEMI Pharmacology<br />
Confusion: How to Choose and Use<br />
Antithrombins (Unfractionated and<br />
Low Molecular Weight Heparins,<br />
Bivalirudin, Fondaparinux) and<br />
Antiplatelet Agents (Aspirin,<br />
Clopidogrel, and Prasugrel)<br />
Gregg W.Stone<br />
Does the Efficacy of Bivalirudin<br />
During PCI Depend on Clopidogrel<br />
Pretreatment?<br />
Matthew Price<br />
Q & A<br />
Adjourn<br />
Angioplasty Summit-TCT Asia Pacific 2009 17 18
Change language